Grupo Planck helps medical technology manufacturers register, launch, and scale in Guatemala and El Salvador. We combine multinational commercial discipline with the region's highest compliance standard.
Guatemala is Central America's largest economy. Its Ministry of Health operates on a US$2.1 billion budget (2026), and the social security institute (IGSS) runs its own procurement with a budget of US$4.2 billion (2026). The 2026 national budget earmarks close to US$200 million for hospital infrastructure, and a fast-growing private hospital sector adds to that demand. Most global manufacturers are still under-represented here. The demand exists; what has been missing is a reliable, compliant channel.
Sources: National Budget 2026, Ministry of Public Finance and Congress of the Republic of Guatemala; IGSS approved budget 2026, Acuerdo No. 1564 de Junta Directiva del IGSS. Figures converted at approximately GTQ 7.7 per US dollar.
IGSS and Ministry of Health tenders, plus international procurement through UNOPS, where Grupo Planck is an active supplier.
Private hospitals and specialty clinics investing in technology upgrades, concentrated in Guatemala City and secondary cities.
Our licenses and operations extend to El Salvador, with a roadmap across Central America.
We take full ownership of the market: regulatory, commercial, clinical, and technical. You get one accountable partner and clean visibility into your funnel.
Sanitary registration and import management under our own license. We carry the regulatory burden so your launch timeline doesn't.
A dedicated specialist per product line, structured launch plans, and CRM-managed pipelines with quarterly reporting you can audit.
Evidence-based training for physicians and nurses, KOL development, and demo programs that build adoption before the first tender.
End-to-end tender management for IGSS, Ministry of Health, and UNOPS processes, from technical specifications to delivery and documentation.
In-house biomedical engineers for installation, preventive maintenance, and after-sales support, protecting your brand long after the sale.
Procurement data analysis, competitive mapping, and a clear market assessment before you commit. We tell you what the opportunity really is.
The company is named after Max Planck as a statement of scientific and ethical principle. We built Grupo Planck for manufacturers whose compliance teams ask hard questions.
We represent European and US manufacturers across nine clinical segments. Each line is owned by a dedicated commercial specialist with clinical training in that specialty.
Our leadership has spent over a decade launching and scaling multinational medical device portfolios across Guatemala's hospitals, public and private.
Biomedical engineer and commercial leader with over 12 years in medical technology, launching and scaling specialty device portfolios of global manufacturers across Guatemala's public and private hospital systems.
Mechanical engineer and commercial leader with 10 years in medical technology, building and leading sales teams for specialty device portfolios across Guatemala. Leads Planck's commercial organization and specialist development.
We build representations meant to last. Before taking on a line, we evaluate the fit as carefully as you evaluate us.
CE-marked or FDA-cleared products with real clinical evidence. Our specialists put their credibility behind every line they carry.
Partners willing to invest in training, demo programs, and registration timelines. Market entry works when both sides treat it as a joint project.
Manufacturers whose own standards match ours: transparent pricing, documented interactions, and zero tolerance for shortcuts.
We plan each representation on a multi-year horizon, with an annual business plan and forecasts shared in both directions.
We map your addressable market in Guatemala: procurement history, competitors, and pricing corridors. Then we give you a clear go or no-go recommendation.
Sanitary registration and importation set up under our own license, with a defined timeline before launch.
Dedicated specialist assigned, KOLs engaged, demo program deployed, first accounts opened in private and public channels.
Quarterly business reviews, CRM-backed forecasts, tender pipeline, and technical service coverage as the line grows.
Most of the registrations we have filed have cleared in 2 to 6 months from complete dossier submission. Registrations run under our own sanitary license with a dedicated regulatory function, so we give you a documented timeline during the market assessment, before you commit, and manage the entire process in-country.
We typically work under exclusive distribution agreements for Guatemala, because market development is an investment we make in your brand: KOL relationships, clinical training, and tender positioning take years to build. Scope and terms are defined together during due diligence.
Every line runs on a CRM-managed pipeline. You receive structured reporting on sales, funnel, forecast, and market activity, monthly or quarterly, in your format if required. Our forecasts are auditable, not aspirational.
Yes, and we encourage it. Our GuateÍntegra certification means our anti-corruption policies, tender procedures, and healthcare-professional interactions are already documented and third-party verified. Most of the work your due-diligence team needs to see already exists on paper.
Both. We manage public tenders (IGSS, Ministry of Health, UNOPS) end-to-end, and maintain direct commercial relationships across the private hospital and specialty clinic sector. A balanced channel mix protects your revenue from single-buyer risk.
Our in-house biomedical engineers handle installation, preventive maintenance, and technical support locally. Clinical training for physicians and nurses is delivered by the dedicated specialist assigned to your line.
Nothing. The initial market assessment is how we decide together whether the partnership makes sense. We would rather tell you "not yet" than launch a line without a real market behind it.
Tell us about your portfolio and we'll come back within five business days with an initial view of your market opportunity. No commitment required.
Or write to us directly:
partnerships@grupoplanck.com
We reply within five business days. Your information is never shared.